ISMB will fund 4 International Travel grants of €400 each to help young scientists participate in the FEBS-MPST2017.

According to the current procedure for ISMB travel grants, applicants should apply directly to the ISMB for these awards. Full details can be found on the ISMB web site www.ismb.org

The travel grants are for PhD students and postdocs up to 5 years post PhD. Grants are for international travel only and will be awarded on the basis of scientific excellence and relevance to matrix biology. The awardees are members of the ISMB and have not recently received a travel grant funded by ISMB. 

To apply for a travel grant, applicants should send their application to the ISMB secretary, including a letter giving details of the meeting, as well as the abstract of their poster/short talk, their curriculum vitae and list of publications.

The applicants for the ISMB International Travel grants should also submit their abstract and the respective Application Form to the Course organizers following the dates given in the General course info.

Deadline for International Travel Awards application: April 1st, 2017

All abstracts with graduate students or postdoctoral fellows as first authors that not received a YTF are subject to scientific evaluation by selected members. The best 3 abstracts will receive the "FEBS-MPST2017 Young Investigator Award" at the end of the course. Each award will be financed with 200€. To be eligible for this award, individuals should also apply with an abstract, a curriculum vitae (one page) and one letter of recommendation. The candidates should include with the application their full address, phone and fax numbers, their e-mail address and an I.D. photo.

The young investigator awards are sponsored by Pharmaceutical firms, lab suppliers, and Publishers.

Deadline for Young Investigator Awards application: February 15^th, 2017

YIA Awardees of FEBS-MPST 2017

1) P57: Unraveling silent pathologic al states by decoding their unique extracellular matrix signature in intestinal inflammation

Elee Shimshoni¹, Ran Afik¹, Anjana Shenoy ², Miri Adler ³, Luca Puricelli ⁴, Alessandro Podestà⁴, Tamar Geiger², Paolo Milani⁴, Uri Alon³ and Irit Sagi¹

¹Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel

² Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine,

Tel Aviv University, Tel Aviv-Yafo, Israel

³Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

⁴CIMAINA and Department of Physics, Universitΰ degli Studi di Milano, Milano, Italy

2) P36: Lack of the extracellul ar matrix proteoglycan lumican in mice exacerbates left ventricular dilatation and contractile dysfunction upon pressure overload

Mohammadzadeh N.^1,2, Lunde IG.^1,2,3, Andenæs K.^1,2, Strand M.E.^1,2, Aronsen J.M.^1,4, Skrbic B.^1,2,5, Marstein H.S.^1,2, Bandlien C.^1,2,5, Nygård S.^1,2, Sjaastad I.^1,2, Chakravarti S. ⁶, Christensen G.^1,2, Engebretsen K.V.^1,2,5, Tønnessen T.^1,2,5

¹Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway

² Center for Heart Failure Research, University of Oslo, Norway

³Department of Genetics, Harvard Medical School, Boston, MA, USA

⁴Bjørknes College, Oslo, Norway

⁵Department of Cardiothoracic Surgery, Oslo University Hospital Ullevεl, Norway

⁶Department of Medicine, Johns Hopkins University, Baltimore, USA

3) P61: Towards the generation of an animal model of chondrodysplasia with joint dislocations gPAPP type

R. Costantini¹, L. Monti¹, C. Paganini¹, Stephan Sonntag², A. Forlino¹, A. Rossi¹

¹Dept. Molecular Medicine, Unit of Biochemistry, University of Pavia, Italy

²PolyGene AG, Rümlang, Switzerland